Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · August 05, 2023

Prognostic Factors and Treatment Strategies in Patients With Brain Metastases From Renal Cell Carcinoma

ESMO Open

 

Additional Info

ESMO Open
An Italian multicenter retrospective real-life analysis of patients with brain metastases from renal cell carcinoma: the BMRCC study
ESMO Open 2023 Jul 17;8(4)101598, V Internò, F Massari, R Rudà, BA Maiorano, O Caffo, G Procopio, S Bracarda, F Atzori, A Passarelli, M Bersanelli, M Stellato, G Fornarini, L Galli, C Ortega, E Zanardi, L Incorvaia, G Facchini, JR Giron Berrios, R Ricotta, M Santoni, C Funaioli, P Trerotoli, C Porta, M Rizzo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Renal Cell Carcinoma Center of Excellence

Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.


Further Reading